General

Safer cells for immunotherapy

Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.

Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019

Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]

2019-02-13T05:02:22+00:00 February 13th, 2019|

Eradicate Cancer 2020 – How well is immunotherapy winning ?

25-27 March 2020 Melbourne Convention and Exhibition Centre

“Success Breeds Success”

The field of immunotherapy against cancers is making unprecedented progress. The Eradicate Cancer Conference “Can advanced immunotherapy make it possible?” held in March 2018 was a resounding success.

It made a great […]

2019-01-29T23:25:31+00:00 January 29th, 2019|

Meet our newest recruit

Research Assistant Callum Docherty explains why immunology is his passion and advancing cancer therapy is his goal.

I’ve always had an insatiable curiosity and a passion for big-picture ideas.  Growing up both my mother and grandmother had cancer.  After such an early confrontation with the absence of health — something most of us take for granted […]

2018-12-18T02:01:36+00:00 December 18th, 2018|

Cartherics Corporate Adviser Dr Ian Nisbet talks about ‘what pisses him off’

WHAT PISSES ME OFF

When it comes to taking ideas to market, Corporate Advisor Ian Nisbet says America’s entrepreneurial ethos leaves risk-averse Australia in the innovation dust.

I’VE WORKED my whole career in the biotechnology/pharmaceutical industry.  Sometimes in business development, sometimes in drug development, sometimes in project management, sometimes in […]

2018-12-10T01:04:58+00:00 November 22nd, 2018|

Next Big Idea Award winners announced

Photograph: L-R: Dr Michael Gantier, Stuart Emmerson, Dr Nick Boyd and Dr Shivani Pasricha

Researchers and students have pitched their innovative ‘Big Ideas’ tackling health conditions ranging from tackling Legionnaires disease to improving exercise science to a panel of research and commercialisation experts.

It was all part of the Next Big Idea […]

2018-09-07T02:00:15+00:00 September 7th, 2018|

Student development evening

A student development evening was held on 13 August 2018 at Monash University Clayton where Professor Graham Jenkin a represented Cartherics Pty Ltd. More information regarding our PhD projects is available on our Opportunities page.

What open days are for ……

  • Help to identify a project area right for you
  • Chat to supervisors about their area of […]
2018-09-07T01:58:53+00:00 August 16th, 2018|

Eradicate Cancer Conference 2108

Our organising committee has been working relentlessly on this inaugural world conference having now assembled an excellent program of 40+ national and international opinion leaders. This conference is indeed something out of the ordinary.

Immunotherapy is on the cusp of revolutionising cancer treatment with some in the field even considering the potential of cure. With […]

2018-07-12T02:19:28+00:00 July 12th, 2018|

CRC-P Grant, 4th round selection announcement – success for Cartherics.

Cartherics has been advised by the Hon Craig Laundy MP (Assistant Minister for Industry, Innovation and Science) that its application “Allogeneic Stem Cell Cancer Immunotherapies” in the 4th Cooperative Research Centres (CRC) Project Funding round has been successful.

Cartherics’ application was one of just 15 successful applications out of a total of 70 received in the 4th […]

2018-07-11T06:18:40+00:00 July 11th, 2018|

Biotech Daily reports ….. Professor Jacques Miller wins Japan prize, January 2018

Professor Jacques Miller a member of Cartherics’ Scientific Advisory Board  wins “The Japan Prize Foundation says Walter and Eliza Hall Institute’s Prof Jacques Miller and Emory’s Prof Max Cooper have won the Japan Prize for Medical and Medicinal Science. A spokesperson for the Foundation told Biotech Daily that Prof Miller and Dr Cooper would share the […]

2018-05-31T07:55:02+00:00 May 31st, 2018|